A detailed history of Wr Wealth Planners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wr Wealth Planners, LLC holds 82 shares of VRTX stock, worth $41,200. This represents 0.01% of its overall portfolio holdings.

Number of Shares
82
Previous 127 35.43%
Holding current value
$41,200
Previous $59,000 35.59%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$460.0 - $505.78 $20,700 - $22,760
-45 Reduced 35.43%
82 $38,000
Q2 2024

Jul 31, 2024

BUY
$392.81 - $485.53 $1,571 - $1,942
4 Added 3.25%
127 $59,000
Q1 2024

Jul 31, 2024

BUY
$407.69 - $446.08 $50,145 - $54,867
123 New
123 $51,000
Q2 2023

Aug 01, 2024

SELL
$314.42 - $351.91 $1,886 - $2,111
-6 Reduced 4.72%
121 $42.6 Million
Q1 2023

Aug 01, 2024

SELL
$283.23 - $323.1 $22,941 - $26,171
-81 Reduced 63.78%
46 $14.5 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wr Wealth Planners, LLC Portfolio

Follow Wr Wealth Planners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wr Wealth Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wr Wealth Planners, LLC with notifications on news.